85.19 Cr
2.37%
BSE Healthcare TRI
INF663L01Z52
5000.0
1000.0
1000
Mr. Anandha Padmanabhan Anjeneyan, Mr. Utsav Mehta, Mr. Vivek Sharma and Mr. Puneet Pal
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| PGIM India Healthcare Fund - Regular Plan - Growth Option | 4.05 | - | - |
| Benchmark | - | - | - |
Equity
Debt
Others
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.69 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 10.34 |
| ASTER DM HEALTHCARE LIMITED EQ | 7.07 |
| JB Chemicals & Pharmaceuticals Limited | 6.39 |
| Dr. Reddys Laboratories Ltd | 6.09 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 5.81 |
| Nuvama Wealth Management Limited | 5.29 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 5.01 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 4.94 |
| Krishna Institute Of Medical Sciences Limited | 4.35 |
| Sector | Holdings (%) |
|---|---|
| Healthcare | 90.73 |
| Chemicals | 2.81 |
| Financial Services | 2.59 |
| Consumer Services | 0.78 |
| Information Technology | 0.66 |